Literature DB >> 23152114

Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.

Mohammed A Nayeem1, Isha Pradhan, S Jamal Mustafa, Christophe Morisseau, John R Falck, Darryl C Zeldin.   

Abstract

The interaction between adenosine and soluble epoxide hydrolase (sEH) in vascular response is not known. Therefore, we hypothesized that lack of sEH in mice enhances adenosine-induced relaxation through A(2A) adenosine receptors (AR) via CYP-epoxygenases and peroxisome proliferator-activated receptor γ (PPARγ). sEH(-/-) showed an increase in A(2A) AR, CYP2J, and PPARγ by 31%, 65%, and 36%, respectively, and a decrease in A(1)AR and PPARα (30% and 27%, respectively) vs. sEH(+/+). 5'-N-ethylcarboxamidoadenosine (NECA, an adenosine receptor agonist), CGS 21680 (A(2A) AR-agonist), and GW 7647 (PPARα-agonist)-induced responses were tested with nitro-l-arginine methyl ester (l-NAME) (NO-inhibitor; 10(-4) M), ZM-241385, SCH-58261 (A(2A) AR-antagonists; 10(-6) M), 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE, an epoxyeicosatrienoic acid-antagonist; 10(-5) M), 12-(3-adamantan-1-yl-ureido) dodecanoic acid (AUDA; 10 μM) or trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB, sEH-inhibitors; 10(-5) M), and T0070907 (PPARγ-antagonist; 10(-7) M). In sEH(-/-) mice, ACh response was not different from sEH(+/+) (P > 0.05), and l-NAME blocked ACh-responses in both sEH(-/-) and sEH(+/+) mice (P < 0.05). NECA (10(-6) M)-induced relaxation was higher in sEH(-/-) (+12.94 ± 3.2%) vs. sEH(+/+) mice (-5.35 ± 5.2%); however, it was blocked by ZM-241385 (-22.42 ± 1.9%) and SCH-58261(-30.04 ± 4.2%). CGS-21680 (10(-6) M)-induced relaxation was higher in sEH(-/-) (+37.4 ± 5.4%) vs. sEH(+/+) (+2.14 ± 2.8%). l-NAME (sEH(-/-), +30.28 ± 4.8%, P > 0.05) did not block CGS-21680-induced response, whereas 14,15-EEZE (-7.1 ± 3.7%, P < 0.05) did. Also, AUDA and t-AUCB did not change CGS-21680-induced response in sEH(-/-) (P > 0.05), but reversed in sEH(+/+) (from +2.14 ± 2.8% to +45.33 ± 4.1%, and +63.37 ± 7.2, respectively). PPARα-agonist did not relax as CGS 21680 (-2.48 ± 1.1 vs. +37.4 ± 5.4%) in sEH(-/-), and PPARγ-antagonist blocked (from +37.4 ± 5.4% to +9.40 ± 3.1) CGS 21680-induced relaxation in sEH(-/-). Our data suggest that adenosine-induced relaxation in sEH(-/-) may depend on the upregulation of A(2A) AR, CYP2J, and PPARγ, and the downregulation of A(1) AR and PPARα.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152114      PMCID: PMC3543649          DOI: 10.1152/ajpregu.00213.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  66 in total

1.  Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

Authors:  Z Yu; F Xu; L M Huse; C Morisseau; A J Draper; J W Newman; C Parker; L Graham; M M Engler; B D Hammock; D C Zeldin; D L Kroetz
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

2.  Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.

Authors:  P Delerive; K De Bosscher; S Besnard; W Vanden Berghe; J M Peters; F J Gonzalez; J C Fruchart; A Tedgui; G Haegeman; B Staels
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo.

Authors:  M G Persson; L E Gustafsson; N P Wiklund; P Hedqvist; S Moncada
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

4.  Comparison of the vascular effects of adenosine in isolated mouse heart and aorta.

Authors:  M A Hassan Talukder; R Ray Morrison; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-01       Impact factor: 4.733

5.  Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.

Authors:  Ayala Luria; Steven M Weldon; Alisa K Kabcenell; Richard H Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

6.  Mechanisms of delayed preconditioning with A1 adenosine receptor activation in porcine coronary smooth muscle cells.

Authors:  Mohammed A Nayeem; S Jamal Mustafa
Journal:  Pol J Pharmacol       Date:  2002 Sep-Oct

7.  Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium.

Authors:  W Abebe; S R Makujina; S J Mustafa
Journal:  Am J Physiol       Date:  1994-05

8.  High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases.

Authors:  Mohammed A Nayeem; Dovenia S Ponnoth; Matthew A Boegehold; Darryl C Zeldin; John R Falck; S Jamal Mustafa
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-24       Impact factor: 3.619

9.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

Authors:  W B Campbell; D Gebremedhin; P F Pratt; D R Harder
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

Review 10.  Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

Authors:  Katherine N Theken; Craig R Lee
Journal:  Pharmacogenomics       Date:  2007-10       Impact factor: 2.533

View more
  12 in total

1.  Drug Delivery and Nanoformulations for the Cardiovascular System.

Authors:  W J Geldenhuys; M T Khayat; J Yun; M A Nayeem
Journal:  Res Rev Drug Deliv       Date:  2017-03-07

2.  Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; Mohammed A Nayeem
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-03       Impact factor: 3.619

3.  Adenosine A2A receptor and vascular response: role of soluble epoxide hydrolase, adenosine A1 receptor and angiotensin-II.

Authors:  Ahmad Hanif; Stephanie O Agba; Catherine Ledent; Stephen L Tilley; Christophe Morisseau; Mohammed A Nayeem
Journal:  Mol Cell Biochem       Date:  2021-01-28       Impact factor: 3.396

Review 4.  Role of oxylipins in cardiovascular diseases.

Authors:  Mohammed A Nayeem
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

5.  High salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels.

Authors:  Isha Pradhan; Catherine Ledent; S Jamal Mustafa; Christophe Morisseau; Mohammed A Nayeem
Journal:  Mol Cell Biochem       Date:  2015-03-05       Impact factor: 3.396

6.  Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels.

Authors:  Vishal R Yadav; Ka L Hong; Darryl C Zeldin; Mohammed A Nayeem
Journal:  Mol Cell Biochem       Date:  2016-09-15       Impact factor: 3.396

Review 7.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

8.  Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A2A receptor and plasma oxylipins.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; John R Falck; Catherine Ledent; Stephen L Tilley; Mohammed A Nayeem
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-09-07       Impact factor: 3.072

9.  Ephx2-gene deletion affects acetylcholine-induced relaxation in angiotensin-II infused mice: role of nitric oxide and CYP-epoxygenases.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Mohammed A Nayeem
Journal:  Mol Cell Biochem       Date:  2019-12-04       Impact factor: 3.396

10.  Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.

Authors:  Ahmad Hanif; Matthew L Edin; Darryl C Zeldin; Christophe Morisseau; Mohammed A Nayeem
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.